These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32327628)

  • 1. Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Jiang WL; Cai DB; Yin F; Zhang L; Zhao XW; He J; Ng CH; Ungvari GS; Sim K; Hu ML; Zheng W; Xiang YT
    Transl Psychiatry; 2020 Apr; 10(1):117. PubMed ID: 32327628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials.
    Wu RR; Zhang FY; Gao KM; Ou JJ; Shao P; Jin H; Guo WB; Chan PK; Zhao JP
    Mol Psychiatry; 2016 Nov; 21(11):1537-1544. PubMed ID: 26809842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metformin treatment of antipsychotic-induced dyslipidemia: analysis of two randomized, placebo-controlled trials].
    Yang Y; Wang X; Kang D; Long Y; Ou J; Guo W; Zhao J; Wu R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Oct; 44(10):1128-1136. PubMed ID: 31857506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.
    Wu RR; Zhao JP; Jin H; Shao P; Fang MS; Guo XF; He YQ; Liu YJ; Chen JD; Li LH
    JAMA; 2008 Jan; 299(2):185-93. PubMed ID: 18182600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.
    Wu RR; Jin H; Gao K; Twamley EW; Ou JJ; Shao P; Wang J; Guo XF; Davis JM; Chan PK; Zhao JP
    Am J Psychiatry; 2012 Aug; 169(8):813-21. PubMed ID: 22711171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study.
    de Silva VA; Dayabandara M; Wijesundara H; Henegama T; Gunewardena H; Suraweera C; Hanwella R
    J Psychopharmacol; 2015 Dec; 29(12):1255-61. PubMed ID: 26510448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
    Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
    Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Zhu XM; Zhang QE; Yang XH; Cai DB; Li L; Li XB; Ng CH; Ungvari GS; Ning YP; Xiang YT
    Schizophr Res; 2019 Apr; 206():13-20. PubMed ID: 30573406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin for Weight Gain and Metabolic Abnormalities Associated With Antipsychotic Treatment: Meta-Analysis of Randomized Placebo-Controlled Trials.
    Zheng W; Li XB; Tang YL; Xiang YQ; Wang CY; de Leon J
    J Clin Psychopharmacol; 2015 Oct; 35(5):499-509. PubMed ID: 26280837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive Reboxetine for Schizophrenia: Meta-analysis of Randomized Double-blind, Placebo-controlled Trials.
    Zheng W; Li XB; Shi ZM; Yang XH; Cai DB; Ng CH; Ungvari GS; Liu WJ; Wu YJ; Wang YY; Ning YP; Xiang YT
    Pharmacopsychiatry; 2020 Jan; 53(1):5-13. PubMed ID: 31207653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the Efficacy and Safety of Adjunctive Rosuvastatin for Dyslipidemia in Patients with Schizophrenia.
    Zheng W; Yang W; Zhang QE; Yang XH; Cai DB; Hu JQ; Ungvari GS; Ng CH; De Hert M; Ning YP; Xiang YT
    Shanghai Arch Psychiatry; 2018 Feb; 30(1):4-11. PubMed ID: 29719353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.
    Baptista T; Martínez J; Lacruz A; Rangel N; Beaulieu S; Serrano A; Arapé Y; Martinez M; de Mendoza S; Teneud L; Hernández L
    Can J Psychiatry; 2006 Mar; 51(3):192-6. PubMed ID: 16618011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials.
    Sun J; Yuan Y; Cai R; Sun H; Zhou Y; Wang P; Huang R; Xia W; Wang S
    BMJ Open; 2015 Mar; 5(3):e007280. PubMed ID: 25818277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials.
    Zheng W; Xiang YT; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Correll CU
    Acta Psychiatr Scand; 2016 Nov; 134(5):385-398. PubMed ID: 27585549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study.
    Carrizo E; Fernández V; Connell L; Sandia I; Prieto D; Mogollón J; Valbuena D; Fernández I; de Baptista EA; Baptista T
    Schizophr Res; 2009 Aug; 113(1):19-26. PubMed ID: 19515536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Li XH; Yang XH; Cai DB; Ungvari GS; Ng CH; Wang SB; Wang YY; Ning YP; Xiang YT
    Psychol Med; 2018 Jan; 48(1):72-81. PubMed ID: 28528597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive metformin for antipsychotic-related hyperprolactinemia: A meta-analysis of randomized controlled trials.
    Zheng W; Yang XH; Cai DB; Ungvari GS; Ng CH; Wang N; Ning YP; Xiang YT
    J Psychopharmacol; 2017 May; 31(5):625-631. PubMed ID: 28372526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis.
    de Silva VA; Suraweera C; Ratnatunga SS; Dayabandara M; Wanniarachchi N; Hanwella R
    BMC Psychiatry; 2016 Oct; 16(1):341. PubMed ID: 27716110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.
    Pfützner A; Schöndorf T; Tschöpe D; Lobmann R; Merke J; Müller J; Lehmann U; Fuchs W; Forst T
    Diabetes Technol Ther; 2011 Jun; 13(6):637-43. PubMed ID: 21457065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.
    Worsley R; Jane F; Robinson PJ; Bell RJ; Davis SR
    Climacteric; 2015 Apr; 18(2):270-7. PubMed ID: 25333776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.